1. Wide en bloc resection
The preferred curative approach whenever feasible, aiming for en bloc removal with negative surgical margins.
2. Proton radiotherapy
Exploits the Bragg peak to deliver conformal high-dose irradiation to the tumor while sparing surrounding tissues, improving local control rates.
3. Intensity-modulated radiotherapy (IMRT)
Modulates beam intensity to conform the high-dose region to tumor geometry, reducing injury to adjacent structures.
4. Targeted therapy
Agents directed against molecular pathways such as brachyury-related signaling may be used for advanced or refractory disease to inhibit tumor growth.
5. Immunotherapy
PD-1/PD-L1 inhibitors activate antitumor immunity; clinical trials suggest potential benefit in advanced disease.
6. Chemotherapy
Conventional cytotoxic agents may be used to control metastatic or advanced disease progression, relieve symptoms, and prolong survival.
7. Pain management
Standardized cancer pain management includes pharmacologic analgesia and interventional approaches to improve quality of life.
8. Neuroprotection
Intraoperative neuromonitoring and function-preserving techniques help maximize neurological preservation and reduce complications.
9. Postoperative rehabilitation
Structured functional training and physical therapy promote recovery and improve activities of daily living.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although chordoma is rare, it is locally destructive, and delayed treatment can lead to severe functional impairment. Surgery-based multimodal therapy is pivotal for improving prognosis and should be individualized according to tumor characteristics. Early diagnosis and standardized management are essential. Patients are advised to seek specialized care promptly; MDT-based multidisciplinary collaboration can maximize functional preservation and prolong survival.
1. Wide en bloc resection
The preferred curative approach whenever feasible, aiming for en bloc removal with negative surgical margins.
2. Proton radiotherapy
Exploits the Bragg peak to deliver conformal high-dose irradiation to the tumor while sparing surrounding tissues, improving local control rates.
3. Intensity-modulated radiotherapy (IMRT)
Modulates beam intensity to conform the high-dose region to tumor geometry, reducing injury to adjacent structures.
4. Targeted therapy
Agents directed against molecular pathways such as brachyury-related signaling may be used for advanced or refractory disease to inhibit tumor growth.
5. Immunotherapy
PD-1/PD-L1 inhibitors activate antitumor immunity; clinical trials suggest potential benefit in advanced disease.
6. Chemotherapy
Conventional cytotoxic agents may be used to control metastatic or advanced disease progression, relieve symptoms, and prolong survival.
7. Pain management
Standardized cancer pain management includes pharmacologic analgesia and interventional approaches to improve quality of life.
8. Neuroprotection
Intraoperative neuromonitoring and function-preserving techniques help maximize neurological preservation and reduce complications.
9. Postoperative rehabilitation
Structured functional training and physical therapy promote recovery and improve activities of daily living.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although chordoma is rare, it is locally destructive, and delayed treatment can lead to severe functional impairment. Surgery-based multimodal therapy is pivotal for improving prognosis and should be individualized according to tumor characteristics. Early diagnosis and standardized management are essential. Patients are advised to seek specialized care promptly; MDT-based multidisciplinary collaboration can maximize functional preservation and prolong survival.